Results 21 to 30 of about 8,311 (256)

The role of seasonal malaria chemoprevention in the effect of azithromycin on child mortality: A secondary analysis of the CHAT cluster randomized clinical trial. [PDF]

PLOS Glob Public Health
Objective: Mass treatment with azithromycin (AZ) and administration of seasonal malaria chemoprevention (SMC) are both effective in reducing mortality among children under 5.
Gebreegziabher EA, Ouattara M, Bountogo M, Coulibaly B, Boudo V, Ouedraogo T, Lebas E, Hu H, O'Brien KS, Hsiang MS, Glidden DV, Arnold BF, Lietman TM, Sié A, Oldenburg CE.   +14 more
europepmc   +3 more sources

Assessing the Acceptability and Feasibility of Five Cycles of Seasonal Malaria Chemoprevention in Côte d’Ivoire [PDF]

Tropical Medicine and Infectious Disease
Seasonal malaria chemoprevention (SMC) is a strategy recommended by the World Health Organization for children aged 3–59 months in the Sahel and sub-Sahel regions where malaria transmission is seasonal.
Orphée Kangah, Issaka Zongo, Alassane Haro, William Yavo   +3 more
doaj   +2 more sources

Supporting evidence-based decisions about the geographic and demographic extensions of seasonal malaria chemoprevention in Benin: A modelling study. [PDF]

PLOS Glob Public Health
Seasonal malaria chemoprevention (SMC) has been implemented yearly in northern Benin since 2019 to reduce the malaria burden in children under 5 years of age.
Lemant J, Champagne C, Houndjo W, Aïssan J, Aïkpon R, Houetohossou C, Kpanou S, Goers R, Affoukou C, Pothin E.   +9 more
europepmc   +2 more sources

Seasonal malaria chemoprevention: successes and missed opportunities [PDF]

Malaria Journal, 2017
Seasonal malaria chemoprevention (SMC) was recommended in 2012 for young children in the Sahel during the peak malaria transmission season. Children are given a single dose of sulfadoxine/pyrimethamine combined with a 3-day course of amodiaquine, once a ...
Matthew E. Coldiron, Lorenz Von Seidlein, Rebecca F. Grais   +2 more
doaj   +3 more sources

Caregiver acceptability of seasonal malaria chemoprevention in two districts in the Upper West region, Ghana: a cross-sectional study. [PDF]

Malar J
Acceptability of malaria chemoprevention interventions by caregivers is crucial for overall programme success. This study assessed coverage and acceptability of Seasonal Malaria Chemoprevention (SMC) in selected communities in the Northern part of Ghana.
Diarra Y, Opoku MM, Amankwa CE, Annor RB, Nonvignon J, Bonful HA.   +5 more
europepmc   +2 more sources

Global medium-term research priority setting for seasonal malaria chemoprevention: results from an eDelphi study. [PDF]

BMJ Glob Health
Introduction Seasonal malaria chemoprevention (SMC) with sulfadoxine-pyrimethamine and amodiaquine (SPAQ) has been delivered in sub-Saharan Africa since 2014, reaching over 40 million children in 2022.
Richardson S, Steele A, Scott S, Ainsworth J, Eckert E, Tchouatieu AM, Sillah JS, Cuomo-Dannenburg G, Okereke E, Okeh DU, Tonks S, Ndiaye JL, Dentinger C, Rassi C, Baker K.   +14 more
europepmc   +2 more sources

Trends in Plasmodium falciparum resistance markers to sulfadoxine-pyrimethamine and amodiaquine over ten years of seasonal malaria chemoprevention in Moissala Health District, Chad. [PDF]

Malar J
Seasonal Malaria Chemoprevention (SMC) has been implemented in Moissala Health District, southern Chad, since 2013 using the standard regimen of sulfadoxine-pyrimethamine (SP) and amodiaquine (AQ).
Grandesso F, Diar MSI, Kouassi F, Sayyad-Hilario J, Ouedraogo P, Djimde AA, Singh S, Dama S.   +7 more
europepmc   +2 more sources

"We witnessed medicines help our children, then we became proud": experiences and acceptability of seasonal malaria chemoprevention in Aweil, South Sudan. [PDF]

Malar J
Malaria remains a significant public health concern, particularly in resource-constrained settings and regions affected by ongoing humanitarian crises, such as Northen Bahr el Ghazal in South Sudan.
Okot F, Sans MS, Viganò E, Rom A, Mubiru D, Baker K, Khan J, Julla A.   +7 more
europepmc   +2 more sources

Malaria parasite carriage before and two years after the implementation of seasonal malaria chemoprevention: a case study of the Saraya health district, southern Senegal [version 2; peer review: 2 approved]

Wellcome Open Research, 2022
Background: Seasonal malaria chemoprevention (SMC) has been adopted and implemented in the southern regions of Senegal in children aged between three and 120 months since 2013. Scaling up this strategy requires its evaluation to assess the impact.
Isaac Akhenaton Manga, Fassiatou Tairou, Mamadou Sarifou BA, Ekoue Kouevidjin, Amadou Seck, Magatte Ndiaye, Doudou Sow, Médoune Ndiop, Khadime Sylla, Alioune Babara Gueye, Mady Ba, Fatou Ba Fall, Ibrahima Diallo, Omar Gaye, Roger Clément Tine, Jean Louis Abdourahim Ndiaye, Babacar Faye   +16 more
doaj   +2 more sources

Patterns of patent and sub-patent Plasmodium falciparum infections in household members of children under seasonal malaria chemoprevention coverage in the health district of Nanoro, Burkina Faso. [PDF]

Malar J
Seasonal Malaria Chemoprevention (SMC) has been adopted since 2014 in Burkina Faso to reduce malaria burden in children under 5 years. However, the intervention’s expected potential has not yet been achieved in real-life conditions, suggesting other ...
Kambou SAE, Sondo P, Kabore B, Bayala IMC, Kouevi AFC, Compaore EW, Millogo KS, Ismaïla B, Rouamba T, Kazienga A, Karim D, Rouamba E, Dahal P, Otienoburu SD, Raman J, Dhorda M, Bamba S, Guérin PJ, Tinto H.   +18 more
europepmc   +2 more sources